Cover Image
市場調查報告書

人類乳突病毒 (HPV) 檢驗的全球市場 (2015∼2019年)

Global HPV Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 295876
出版日期 內容資訊 英文 70 Pages
訂單完成後即時交付
價格
Back to Top
人類乳突病毒 (HPV) 檢驗的全球市場 (2015∼2019年) Global HPV Testing Market 2015-2019
出版日期: 2015年06月17日 內容資訊: 英文 70 Pages
簡介

所謂人類乳突病毒 (HPV) ,是總合200種以上相關病毒的集合體,未伴隨任何症狀便讓感染疾病發病,有這種共通的特徵。其中40種以上傳染性非常高,透過直接性交,使男性器、女性器雙方傳染。大半的HPV感染疾病是無害的且自然治癒,不過,部分高風險的 (性器官相關的) HPV有持續感染性,可能引起子宮頸癌和陰莖癌、肛門癌、陰道癌、口咽癌。許多人定期進行HPV檢驗作為預防手段。HPV檢驗,從子宮頸部採取細胞樣品,檢查有無病毒遺傳物質。全球HPV檢驗市場,預計從2014年到2019年,以16.17%的年複合成長率(CAGR)擴大。

本報告提供全球人類乳突病毒 (HPV) 檢驗市場現狀與未來預測、市場成長因素與課題、主要供應商簡介 (企業、產業概要、主要產品、各部門、各地區的收益額、產業策略、SWOT分析等) 等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 美國的HPV檢驗市場
  • 波特的五力分析

第7章 人類乳突病毒 (HPV):概要

  • HPV的種類
  • HPV和子宮頸部癌症
    • 發病數量、患病人數
    • 症狀
    • 診斷

第8章 醫療費償付制度和目標範圍:概要

第9章 地區區分

  • 南北美洲的HPV檢驗市場
  • 歐洲、中東、非洲地區 (EMEA) 的HPV檢驗市場
  • 亞太地區的HPV檢驗市場

第10章 購買標準

第11章 市場成長因素

第12章 成長因素與其影響

第13章 市場課題

第14章 成長因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭模式
    • 主要消息
  • 市場佔有率分析
  • 其他卓越供應商

第18章 主要供應商分析

  • Abbott Diagnostics
  • Hologic
  • Qiagen
  • Roche Diagnostics

第19章 相關報告

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR6293

About HPV

HPV refers to a group of more than 200 related viruses commonly causing infections that do not have any symptoms. Among these, more than 40 types of HPV cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals undergo regular HPV tests as a preventive measure. HPV tests help detect the viral genetic material in a cell sample taken from the cervix.

Technavio's analysts forecast the global HPV testing market to grow at a CAGR of 16.17% over the period 2014-2019.

Covered in this Report

This report covers the present and future scenarios of the global HPV testing market for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of HPV testing kits and detection systems. The report includes the segmentation of the market based on the following three regions: the Americas, APAC, and EMEA.

Technavio's report, Global HPV Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Diagnostics
  • Hologic
  • Qiagen
  • Roche Diagnostics

Other Prominent Vendors

  • Arbor Vita
  • Becton, Dickinson and Company
  • Cepheid
  • Delphi Bioscience
  • DiaCarta
  • Diasorin
  • Fujirebio
  • Genera Biosystems
  • IncellDx
  • OralDNA Labs
  • Quest Diagnostics
  • Seegene
  • Trovagene
  • Ventana Medical Systems

Market Driver

  • Increased Incidence of HPV
  • For a full, detailed list, view our report

Market Challenge

  • Lack of Public Awareness
  • For a full, detailed list, view our report

Market Trend

  • Co-testing with HPV and Pap Tests
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. HPV Testing Market in US
    • 06.3.1. Market Size and Forecast
  • 06.4. Five Forces Analysis

07. HPV: An Overview

  • 07.1. HPV Types
  • 07.2. HPV and Cervical Cancer
    • 07.2.1. Incidence and Prevalence
    • 07.2.2. Symptoms
    • 07.2.3. Diagnosis

08. Reimbursement and Coverage: An Overview

09. Geographical Segmentation

  • 09.1. HPV Testing Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. HPV Testing Market in EMEA
    • 09.2.1. Market Size and Forecast
  • 09.3. HPV Testing Market in APAC
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and Their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and Their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
  • 17.2. Market Share Analysis 2014
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Diagnostics
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Geographical Presence
    • 18.1.4. SWOT Analysis
  • 18.2. Hologic
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Sales by Geography
    • 18.2.6. Business Strategy
    • 18.2.7. Key Developments
    • 18.2.8. SWOT Analysis
  • 18.3. Qiagen
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Product Segmentation by Revenue 2013
    • 18.3.4. Product Segmentation by Revenue 2012 and 2013
    • 18.3.5. Geographical Segmentation by Revenue 2013
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. Roche Diagnostics
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation by Revenue 2014
    • 18.4.4. Business Segmentation by Revenue 2013 and 2014
    • 18.4.5. Geographical Segmentation by Revenue 2014
    • 18.4.6. Business Strategy
    • 18.4.7. Recent Developments
    • 18.4.8. SWOT Analysis

19. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global HPV Testing Market 2014-2019 ($ millions)
  • Exhibit 3: HPV Testing Market in US 2014-2019 ($ millions)
  • Exhibit 4: Snapshot: Cervical Cancer
  • Exhibit 5: Reimbursement Perspectives of Healthcare Entities
  • Exhibit 6: Segmentation of Global HPV Testing Market by Geography 2014
  • Exhibit 7: HPV Testing Market in Americas 2014-2019 ($ millions)
  • Exhibit 8: HPV Testing Market in EMEA 2014-2019 ($ millions)
  • Exhibit 9: HPV Testing Market in APAC 2014-2019 ($ millions)
  • Exhibit 10: Segmentation of Global HPV Testing Market by Region 2014-2019
  • Exhibit 11: Global HPV Testing Market: YoY Growth Rate by Region 2014-2019
  • Exhibit 12: Abbott Diagnostics: Key Takeaways
  • Exhibit 13: Hologic: Key Takeaways
  • Exhibit 14: Qiagen: Key Takeaways
  • Exhibit 15: Roche Diagnostics: Key Takeaways
  • Exhibit 16: Abbott Diagnostics: Geographical Presence
  • Exhibit 17: Hologic: Revenue Segmentation 2013
  • Exhibit 18: Revenue Comparison FY2012 and FY2013 ($ millions)
  • Exhibit 19: Hologic: Sales by Geography 2013
  • Exhibit 20: Qiagen: Product Segmentation by Revenue 2013
  • Exhibit 21: Qiagen: Product Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 22: Qiagen: Geographical Segmentation by Revenue 2013
  • Exhibit 23: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 24: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
  • Exhibit 25: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Back to Top